9. The prevalence of depression, anxiety, and insomnia in COVID-19 patients in the COVID-19 hospital, Hanoi
Main Article Content
Abstract
A cross-sectional study on depression, anxiety, and insomnia in COVID-19 patients was conducted at the COVID-19 Treatment Hospital, Hanoi Medical University Hospital, from March to June 2022. Data was collected through interviews with patients using a questionnaire designed for the study. The study included 83 COVID-19 patients where the rates of depression, anxiety, and insomnia were 54.2%, 33.7%, and 53.0%, respectively. Factors associated with depression included moderate to severe COVID-19 illness, psychological distress, and insomnia. Similarly, having ≥ 2 underlying conditions and COVID-19-related fear were associated with anxiety. The study revealed that hospitalized COVID-19 patients have a high prevalence of mental disorders such as depression, anxiety, and insomnia.
Article Details
Keywords
Mental disorder, depression, anxiety, insomnia, COVID-19
References
2. Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. The Lancet. 2020; 395(10224): e37-e38. doi:10.1016/S0140-6736(20)30309-3.
3. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021; 594(7862): 259-264. doi:10.1038/s41586-021-03553-9.
4. Zhang J, Lu H, Zeng H, et al. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain Behav Immun. 2020; 87:49-50. doi:10.1016/j.bbi.2020.04.031.
5. Sultana S, Ananthapur V. COVID-19 and its impact on neurological manifestations and mental health: the present scenario. Neurol Sci. 2020; 41(11): 3015-3020. doi:10.1007/s10072-020-04695-w.
6. Nikopoulou VA, Holeva V, Parlapani E, et al. Mental Health Screening for COVID-19: a Proposed Cutoff Score for the Greek Version of the Fear of COVID-19 Scale (FCV-19S). Int J Ment Health Addict. 2022; 20(2): 907-920. doi:10.1007/s11469-020-00414-w.
7. J D, F Z, W H, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021; 1486(1). doi:10.1111/nyas.14506.
8. Lu G, Zhang Y, Zhang H, et al. Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave. Emerg Microbes Infect. 11(1): 2045-2054. doi:10.1080/22221751.2022.2109517.
9. Ngasa SN, Tchouda LAS, Abanda C, et al. Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in Laquintinie Hospital Douala, Cameroon. PloS One. 2021; 16(12): e0260819. doi:10.1371/journal.pone.0260819.
10. Alamri HS, Mousa WF, Algarni A, et al. Mental Health of COVID-19 Patients-A Cross-Sectional Survey in Saudi Arabia. Int J Environ Res Public Health. 2021; 18(9): 4758. doi:10.3390/ijerph18094758.
11. Tran QD, Vu TQC, Phan NQ. Depression prevalence in Vietnam during the Covid-19 pandemic: A systematic review and meta-analysis. Ethics Med Public Health. 2022; 23:100806. doi:10.1016/j.jemep.2022.100806.
12. Yuan K, Zheng YB, Wang YJ, et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022; 27(8): 3214-3222. doi:10.1038/s41380-022-01638-z.
13. Meaklim H, Saunders WJ, Byrne ML, et al. Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic. J Affect Disord. 2023;322:52-62. doi:10.1016/j.jad.2022.11.021